Trial Profile
24 - Week Flibanserin 100mg for the Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal Women in Noth America.
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 02 Aug 2018
Price :
$35
*
At a glance
- Drugs Flibanserin (Primary)
- Indications Female sexual dysfunction
- Focus Registrational; Therapeutic Use
- Acronyms PLUMERIA
- Sponsors Boehringer Ingelheim; Sprout Pharmaceuticals
- 13 Jul 2018 According to a Bausch Health Companies media release, Valeant Pharmaceuticals International changed its name to Bausch Health Companies
- 16 May 2017 Results of a post-hoc analysis from three 24-week trials presented at the 112th Annual Meeting of the American Urological Association
- 03 Dec 2010 Additional trial centres identified as reported by ClinicalTrials.gov.